Oral Docetaxel in Patients With Normal or Impaired Liver Function

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2017

Primary Completion Date

February 29, 2020

Study Completion Date

April 30, 2020

Conditions
Solid Tumor, AdultImpaired Liver Function
Interventions
DRUG

ModraDoc006/r

Treatment with weekly ModraDoc006 (oral docetaxel) 10mg tablets in combination with ritonavir 100mg tablets in fed or fasting condition

Trial Locations (1)

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam

Sponsors
All Listed Sponsors
lead

Modra Pharmaceuticals

INDUSTRY

NCT05084456 - Oral Docetaxel in Patients With Normal or Impaired Liver Function | Biotech Hunter | Biotech Hunter